This page is no longer updated. It has been superseded by the Business insights and impacts on the UK economy dataset page (see link in Notices). It contains comprehensive weighted datasets for Wave 7 onwards. All future BICS datasets will be available there. The datasets on this page include mainly unweighted responses from the voluntary fortnightly business survey, which captures businesses’ responses on how their turnover, workforce prices, trade and business resilience have been affected in the two-week reference period, up to Wave 17.

Due to changes in the collection and availability of data on COVID-19 this page will no longer be updated. The webpage will no longer be available as of 11 May 2023. On-going, reliable sources of data for COVID-19 are available via the COVID-19 dashboard, Office for National Statistics, and the UKHSA This page provides a weekly summary of data on deaths related to COVID-19 published by NHS England and the Office for National Statistics. More frequent reporting on COVID-19 deaths is now available here, alongside data on cases, hospitalisations, and vaccinations. This update contains data on deaths related to COVID-19 from: NHS England COVID-19 Daily Deaths - last updated on 28 June 2022 with data up to and including 27 June 2022. ONS weekly deaths by Local Authority - last updated on 16 August 2022 with data up to and including 05 August 2022. Summary notes about each these sources are provided at the end of this document. Note on interpreting deaths data: statistics from the available sources differ in definition, timing and completeness. It is important to understand these differences when interpreting the data or comparing between sources. Weekly Key Points An additional 24 deaths in London hospitals of patients who had tested positive for COVID-19 and an additional 5 where COVID-19 was mentioned on the death certificate were announced in the week ending 27 June 2022. This compares with 40 and 3 for the previous week. A total of 306 deaths in hospitals of patients who had tested positive for COVID-19 and 27 where COVID-19 was mentioned on the death certificate were announced for England as whole. This compares with 301 and 26 for the previous week. The total number of COVID-19 deaths reported in London hospitals of patients who had tested positive for COVID-19 is now 19,102. The total number of deaths in London hospitals where COVID-19 was mentioned on the death certificate is now 1,590. This compares to figures of 119,237 and 8,197 for English hospitals as a whole. Due to the delay between death occurrence and reporting, the estimated number of deaths to this point will be revised upwards over coming days These figures do not include deaths that occurred outside of hospitals. Data from ONS has indicated that the majority (79%) of COVID-19 deaths in London have taken place in hospitals. Recently announced deaths in Hospitals 21 June 22 June 23 June 24 June 25 June 26 June 27 June London No positive test 0 0 1 4 0 0 0 London Positive test 3 7 2 10 0 0 2 Rest of England No positive test 2 6 4 4 0 0 6 Rest of England Positive test 47 49 41 58 6 0 81 16 May 23 May 30 May 06 June 13 June 20 June 27 June London No positive test 14 3 4 0 4 3 5 London Positive test 45 34 55 20 62 40 24 Rest of England No positive test 41 58 33 23 47 23 22 Rest of England Positive test 456 375 266 218 254 261 282 Deaths by date of occurrence 21 June 22 June 23 June 24 June 25 June 26 June 27 June London 20,683 20,686 20,690 20,691 20,692 20,692 20,692 Rest of England 106,604 106,635 106,679 106,697 106,713 106,733 106,742 Interpreting the data The data published by NHS England are incomplete due to: delays in the occurrence and subsequent reporting of deaths deaths occurring outside of hospitals not being included The total deaths reported up to a given point are therefore less than the actual number that have occurred by the same point. Delays in reporting NHS provide the following guidance regarding the delay between occurrence and reporting of deaths: Confirmation of COVID-19 diagnosis, death notification and reporting in central figures can take up to several days and the hospitals providing the data are under significant operational pressure. This means that the totals reported at 5pm on each day may not include all deaths that occurred on that day or on recent prior days. The data published by NHS England for reporting periods from April 1st onward includes both date of occurrence and date of reporting and so it is possible to illustrate the distribution of these reporting delays. This data shows that approximately 10% of COVID-19 deaths occurring in London hospitals are included in the reporting period ending on the same day, and that approximately two-thirds of deaths were reported by two days after the date of occurrence. Deaths outside of hospitals The data published by NHS England does not include deaths that occur outside of hospitals, i.e. those in homes, hospices, and care homes. ONS have published data for deaths by place of occurrence. This shows that, up to 05 August, 79% of deaths in London recorded as involving COVID-19 occurred in hospitals (this compares with 44% for all causes of death). This would suggest that the NHS England data may underestimate overall deaths from COVID-19 by around 20%. Comparison of data sources Note on data sources NHS England provides numbers of patients who have died in hospitals in England and had tested positive for COVID-19, and from 25 April, the number of patients where COVID-19 is mentioned on the death certificate and no positive COVID-19 test result was received. Figures are updated each day at 2pm with deaths reported up to 5pm the previous day. There is a delay between the occurrence of a death to it being captured in the daily reporting. The data can be presented both as reported deaths by day and death occurrences by day. Reported occurrences for recent days should be considered incomplete as likely to be revised upwards as more data becomes available. The location of a death reflects the location of the hospital in which it occurred. Source: NHS England COVID-19 Daily Deaths The Office for National Statistics publishes deaths for England and Wales by the week in which they were registered. Due to the delay between the occurrence of a death and its registration, many deaths that occur in a given week will appear in the data for a subsequent week. For 2018, ONS estimated that 74% of deaths were registered within seven days. Additional delays in registration can occur over public holidays, with significant changes in numbers being observable over Easter and Christmas. The location of a death reflects the usual residence of the deceased. There are some differences in total numbers reported for different geographical levels. The figures published at the local authority level have been used in this analysis. The data is updated each Tuesday at 9.30am with data for the week ending eleven days prior. For the 2020 series, ONS has included the number of deaths where coronavirus (COVID-19) was mentioned on the death certificate. This data includes deaths for all places of occurrence. The ONS started publishing deaths in care homes notified to the Care Quality Commission on 28th April for local authorities in England by date of notification. This data includes an additional week of data compared to the main ONS publication. Source: Deaths registered weekly in England and Wales, provisional, Death registrations and occurrences by local authority, Deaths in care homes notified to the Care Quality Commission, report

The materials presented here are a supporting dataset for a project to evaluate the performance of point of care (lateral flow) immunoassay test devices versus enzyme linked immunosorbent assay (ELISA) for the detection of antibodies to SARS-CoV-2.Our work was undertaken with ethical approval from the National Health Service Blood and Transplant (NHSBT) ethics, providing donor consent for plasma use; NIHR Biobank REC agreement (REC 13/NW/0017; IRAS 87824); International Severe Acute Respiratory and Emerging Infection Consortium (‘ISARIC’) approval by the South Central (Oxford C) Research Ethics Committee in England (Ref: 13/SC/0149), and Scotland A Research Ethics Committee in Scotland (Ref: 20/SS/0028). The UK Government Department of Health and Social Care selected the lateral flow devices for testing. Otherwise, the funders had no role in study design or in the collection, analysis, and interpretation of data.Material provided is as follows:1. STARD checklist2. Supplementary table S1. Metadata describing origin and characteristics of designated negative controls and individuals with confirmed SARS-CoV-2 infection (provided as a separate .xlsx file). 3. Supplementary material.pdf- Supplementary Figure S1: Sensitivity and specificity of lateral flow devices compared with RT-PCR confirmed cases and pre-pandemic controls (panels A and B) and compared with ELISA results (panels C and D). - Supplementary Figure S2: Comparison between ELISA and LFIA for SARS-CoV-2 designated negative and positive plasma. - Supplementary table S2. Summary grid presenting the number of samples from each cohort tested using different assay platforms. - Supplementary table S3. Multivariable regression models for relationship between ELISA IgM and IgG readings and covariates in RT-PCR positive cases. - Supplementary Table S4. Results of nine lateral flow immunoassays (LFIA) devices and an ELISA assay, tested with plasma classified as positive (RT-PCR positive) obtained from patients ≥10 days after onset of symptoms. - Supplementary Table S5. Results of nine lateral flow immunoassays (LFIA) devices, tested with plasma classified as positive and negative using ELISA as an alternative reference standard (n=81-90 per LFIA device). Different manufacturers are designated A-I. 95% confidence intervals (CI) are presented for each point estimate.4. Supplementary table S6: Results of all assays performed and relevant metadata (provided as a separate .xlsx file).

Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.

Context

Mental Health Services Monthly Statistics

This publication provides the most timely picture available of people using NHS funded secondary mental health, learning disabilities and autism services in England. These are experimental statistics which are undergoing development and evaluation. This information will be of use to people needing access to information quickly for operational decision making and other purposes. More detailed information on the quality and completeness of these statistics is made available later in our Mental Health Bulletin: Annual Report publication series.

• COVID-19 and the production of statistics

Due to the coronavirus illness (COVID-19) disruption, it would seem that this is now starting to affect the quality and coverage of some of our statistics, such as an increase in non-submissions for some datasets. We are also starting to see some different patterns in the submitted data. For example, fewer patients are being referred to hospital and more appointments being carried out via phone/telemedicine/email. Therefore, data should be interpreted with care over the COVID-19 period.

Content

Time period covered Feb 1, 2020 - April 31, 2020

Area covered England

Acknowledgements

reference: Mental Health Services Monthly Statistics

Author: Community and Mental Health Team, NHS Digital
Responsible Statistician: Tom Poupart, Principal Information Analyst
Public Enquiries: Telephone: 0300 303 5678
Email: enquiries@nhsdigital.nhs.uk
Press enquiries should be made to: Media Relations Manager: Telephone: 0300 303 3888

Published by NHS Digital part of the Government Statistical Service Copyright © 2020 Health and Social Care Information Centre. The Health and Social Care Information Centre is a non-departmental body created by statute, also known as NHS Digital.

You may re-use this document/publication (not including logos) free of charge in any format or medium, under the terms of the Open Government Licence v3.0.
To view this licence visit To view this licence visit www.nationalarchives.gov.uk/doc/open-government-licence www.nationalarchives.gov.uk/doc/open-government-licence or write to the Information Policy Team, The National Archives, or write to the Information Policy Team, The National Archives, Kew, Richmond, Surrey, TW9 4DU Kew, Richmond, Surrey, TW9 4DU; or email: psi@nationalarchives.gsi.gov.uk or email: psi@nationalarchives.gsi.gov.uk

Cover by-

Inspiration

This dataset is to solve the challenge- UNCOVER COVID-19 Challenge, United Network for COVID Data Exploration and Research. This data is scraped in hopes of solving the task - Mental health impact and support services.

Task Details Can we predict changes in demand for mental health services and how can we ensure access? (by region, social/economic/demographic factors, etc). Are there signs of shifts in mental health challenges across demographies, whether improvements or declines, as a result of COVID-19 and the various measures implement to contain the pandemic?

Further information may be found on the GOV.UK Community Life Survey webpage.

Community Life COVID-19 Re-contact Survey, 2020
The re-contact survey (CLRS) is a follow-up to the Community Life Survey (CLS). The DCMS commissioned the CLRS to provide data on how the COVID-19 pandemic has affected volunteering, charitable giving, social cohesion, wellbeing and loneliness in England. The two waves of data are based on the 2,812 respondents who participated in both waves of the research:

• Wave 1 (pre-pandemic) survey respondents who participated in the CLS from July 2018 through to February 2020.
• Wave 2 (during the pandemic) survey: respondents who took part in a follow-up survey from 7-26 July 2020.

Further information may be found in the https://www.gov.uk/government/statistics/community-life-covid-19-re-contact-survey-2020-main-report/2-methodology-and-interpretation-community-life-recontact-survey-2020">Community Life COVID-19 Re-contact Survey 2020- Main Report and the https://www.gov.uk/government/statistics/community-life-covid-19-re-contact-survey-2020-main-report/2-methodology-and-interpretation-community-life-recontact-survey-2020">Methodology and Interpretation - Community Life COVID-19 Re-Contact Survey 2020 report.

The National Prostate Cancer Audit (NPCA) evaluates patterns of care and outcomes and reports on diagnosis, treatment and outcomes for men diagnosed with prostate cancer in England and Wales. This second publication of the NPCA State of the Nation report in 2025 reflects the move to the National Cancer Audit Collaborating Centre (NATCAN) reporting cycle. The NPCA derives its indicators using information that is routinely collected by the NHS as part of the care and support given to men diagnosed with prostate cancer, rather than data collected specifically for the Audit. For men diagnosed or treated in England, the data are collated, maintained and quality assured by NHS England’s National Disease Registration Service (NDRS). For men diagnosed or treated in Wales, data are provided by Wales Cancer Network (WCN) using the Cancer Network Information System Cymru (CaNISC) or Cancer Dataset Form (CDF). We use the National Cancer Registration Dataset (NCRD) for England, which is considered the ‘gold standard’ because it draws data from various sources. It also benefits from enhanced data processing by cancer registration officers and follow-up from NHS hospital trusts. NCRD data is currently available for patients diagnosed up to December 2022. The Rapid Cancer Registration Dataset (RCRD) includes proxy tumour registrations, providing more up-to-date data but with less accuracy than the NCRD. The RCRD is used in the NPCA Data Dashboard, updated quarterly, and in section 4 of this report. Data were impacted by the COVID-19 pandemic and so will be atypical to some degree during 2020-21. We present results from eight key performance indicators (PIs) in the management of prostate cancer, as well as the variation in performance among providers in England and Wales. For the first time, we report the proportion of men with metastatic disease who receive systemic treatment intensification (PI4a and PI4b) and report the proportion of genitourinary complications occurring after radiotherapy to the prostate, with or without pelvic lymph nodal radiation (PI8). Please refer to the NPCA methodology supplement for comprehensive details regarding this report’s data sources and methodology. Additional supplementary materials, including a glossary of technical terms, an appendix, an action plan template, a patient and public-friendly summary, details of our outlier process and each NHS provider’s results for data completeness and performance indicators, are available on the NPCA State of the Nation report 2025 webpage.

The Greater London Authority (GLA) commissioned the University of Manchester to conduct a rapid evidence review to document and understand the impact of COVID-19 (in terms of both health and the broader impacts on existing social and economic inequalities) on those with protected characteristics, as well as those living in poorer, or more precarious, socioeconomic circumstances, paying particular attention to its effect in London. The report provides the outcomes of the review, as well as a series of recommendations, which are focused on identifying tractable policy solutions in order to prevent, or mitigate, the inequalities in relation to protected characteristics and socioeconomic position that result from the COVID-19 pandemic and policy responses to it. Also available to download below is a spreadsheet documenting the formalised literature review searches.

An October 2021 report explored the impact of the coronavirus (COVID-19) pandemic on the cultural out-of-home industry in the United Kingdom between 2020 and the first half of 2021. The study showed that the night time economy suffered the most as a result of the pandemic, having experienced revenue losses of roughly ** billion British pounds between March 2020 and June 2021. Meanwhile, the daytime economy lost approximately ** billion British pounds in the same period. Overall, the cultural out-of-home industry lost over *** billion British pounds across all sectors.

This dataset reports the uptake of at least one dose of the COVID-19 vaccine among patients registered with GP practices in England. It provides a measure of immunisation coverage and supports monitoring of public health efforts to reduce the spread and severity of COVID-19. The data is sourced from Immform, EMIS Health, and TPP systems.

Rationale

Vaccination is a critical tool in controlling the COVID-19 pandemic. Monitoring vaccine uptake helps identify gaps in coverage, inform targeted outreach, and evaluate the effectiveness of immunisation campaigns. This indicator supports efforts to increase vaccine uptake and protect vulnerable populations.

Numerator

The numerator is the number of patients who have received at least one dose of a COVID-19 vaccine.

Denominator

The denominator is the total number of patients registered with GP practices, as recorded in the Immform-EMIS Health and TPP systems.

Caveats

Automated data collection is only possible from GP practices whose IT suppliers support automatic extraction. Some organisations may not have responded or submitted data, which could affect completeness and accuracy.

External References

More information is available from the following source:

Immform COVID-19 Collections Portal

Localities ExplainedThis dataset contains data based on either the resident locality or registered locality of the patient, a distinction is made between resident locality and registered locality populations:Resident Locality refers to individuals who live within the defined geographic boundaries of the locality. These boundaries are aligned with official administrative areas such as wards and Lower Layer Super Output Areas (LSOAs).Registered Locality refers to individuals who are registered with GP practices that are assigned to a locality based on the Primary Care Network (PCN) they belong to. These assignments are approximate—PCNs are mapped to a locality based on the location of most of their GP surgeries. As a result, locality-registered patients may live outside the locality, sometimes even in different towns or cities.This distinction is important because some health indicators are only available at GP practice level, without information on where patients actually reside. In such cases, data is attributed to the locality based on GP registration, not residential address.

Click here to explore more from the Birmingham and Solihull Integrated Care Partnerships Outcome Framework.

The Taking Part survey is a continuous face to face household survey of adults aged 16 and over in England (and children aged 5 to 15 years old). The survey provides evidence for the Department for Digital, Culture, Media & Sport (DCMS) for measuring engagement with the cultural sectors in England. This report summarises the results from the 2019/20 adult survey and provides comparisons between London and the rest of England. It should be noted that all of the fieldwork took place prior to the COVID-19 pandemic. Fieldwork was terminated before its intended end date due to the COVID-19 coronavirus pandemic. DCMS do not expect that either the pandemic or reduced fieldwork has affected the accuracy of the estimates. Further details of the breakdowns presented in this report can be accessed through the data tables on the Taking Part survey webpage.

The Family Resources Survey (FRS) has been running continuously since 1992 to meet the information needs of the Department for Work and Pensions (DWP). It is almost wholly funded by DWP.

The FRS collects information from a large, and representative sample of private households in the United Kingdom (prior to 2002, it covered Great Britain only). The interview year runs from April to March.

The focus of the survey is on income, and how much comes from the many possible sources (such as employee earnings, self-employed earnings or profits from businesses, and dividends; individual pensions; state benefits, including Universal Credit and the State Pension; and other sources such as savings and investments). Specific items of expenditure, such as rent or mortgage, Council Tax and water bills, are also covered.

Many other topics are covered and the dataset has a very wide range of personal characteristics, at the adult or child, family and then household levels. These include education, caring, childcare and disability. The dataset also captures material deprivation, household food security and (new for 2021/22) household food bank usage.

The FRS is a national statistic whose results are published on the gov.uk website. It is also possible to create your own tables from FRS data, using DWP’s Stat Xplore tool. Further information can be found on the gov.uk Family Resources Survey webpage.

Secure Access FRS data
In addition to the standard End User Licence (EUL) version, Secure Access datasets, containing unrounded data and additional variables, are also available for FRS from 2005/06 onwards - see SN 9256. Prospective users of the Secure Access version of the FRS will need to fulfil additional requirements beyond those associated with the EUL datasets. Full details of the application requirements are available from http://ukdataservice.ac.uk/media/178323/secure_frs_application_guidance.pdf" style="background-color: rgb(255, 255, 255);">Guidance on applying for the Family Resources Survey: Secure Access.

FRS, HBAI and PI
The FRS underpins the related Households Below Average Income (HBAI) dataset, which focuses on poverty in the UK, and the related Pensioners' Incomes (PI) dataset. The EUL versions of HBAI and PI are held under SNs 5828 and 8503, respectively. The Secure Access versions are held under SN 7196 and 9257 (see above).

FRS 2022-23

The impact of the coronavirus (COVID-19) pandemic on the FRS 2022-23 survey was much reduced when compared with the two previous survey years. Throughout the year, there was a gradual return to pre-pandemic fieldwork practices, with the majority of interviews being conducted in face-to-face mode. The achieved sample was just over 25,000 households. Users are advised to consult the FRS 2022-23 Background Information and Methodology document for detailed information on changes, developments and issues related to the 2022-23 FRS data set and publication. Alongside the usual topics covered, the 2022-2023 FRS also includes variables for Cost of Living support, including those on certain state benefits; energy bill support; and Council Tax support. See documentation for further details.

FRS 2021-22 and 2020-21 and the coronavirus (COVID-19) pandemic

The coronavirus (COVID-19) pandemic has impacted the FRS 2021-22 and 2020-21 data collection in the following ways:

• In 2020-21, fieldwork operations for the FRS were rapidly changed in response to the coronavirus (COVID-19) pandemic and the introduction of national lockdown restrictions. The established face-to-face interviewing approach employed on the FRS was suspended and replaced with telephone interviewing for the whole of the 2020-21 survey year.

• This change impacted both the size and composition of the achieved sample. This shift in mode of interview has been accompanied by a substantial reduction in the number of interviews achieved: just over 10,000 interviews were achieved this year, compared with 19,000 to 20,000 in a typical FRS year. While we made every effort to address additional biases identified (e.g. by altering our weighting regime), some residual bias remains. Please see the FRS 2020-21 Background Information and Methodology document for more information.
• The FRS team have published a technical report for the 2020-21 survey, which provides a full assessment of the impact of the pandemic on the statistics. In line with the Statistics Code of Practice, this is designed to assist users with interpreting the data and to aid transparency over decisions and data quality issues.

• In 2021-22, the interview mode was largely telephone, with partial return to face-to-face interviews towards end of survey year. The achieved sample was over 16,000 households. This is a return towards the number expected in a normal survey year (around 20,000 households).
• In both survey years, there remain areas where users are advised to exercise caution when making comparisons to other survey years. More details on how the results for the 2020 to 2021 and 2021-22 survey years were affected by the coronavirus (COVID-19) pandemic can be found in the FRS 2020 to 2021 Background Information and Methodology and FRS 2021 to 2022 Background Information and Methodology.

The FRS team are seeking users' feedback on the 2020-21 and 2021-22 FRS. Given the breadth of groups covered by the FRS data, it has not been possible for DWP statisticians to assess or validate every breakdown which is of interest to external researchers and users. Therefore, the FRS team are inviting users to let them know of any insights you may have relating to data quality or trends when analysing these data for your area of interest. Please send any feedback directly to the FRS Team Inbox: team.frs@dwp.gov.uk

Latest edition information

For the second edition (May 2025), the data were redeposited. The following changes have been made:

• An ONS-delivered fix to the highest level of qualification (EDUCQUAL) which for several adults had been erroneously recorded.
• For ESA (benefit 16 on the BENEFITS table) the associated VAR3 has now been populated using ESA admin data, to show whether cases are Support Group etc.
• For Pension Credit recipients (benefit 4 on the BENEFITS table) adding the low-income benefits and tax credits Cost of Living Payment as benefit 124; with its flag CLPAYIRB set on the ADULT table.

First reported in Wuhan, China, in December 2019, now more than 846,200 confirmed cases of COVID-19 are spread across 187 countries worldwide. The US and several countries in Europe such as Italy, Spain, and Belgium have continued to see a decrease in daily cases. Russia, Brazil, and Latin American countries are seeing increasing trends. India has also seen an increase in the number of new cases reported despite strict distancing measures taken early on.
Special populations analysis covered in the report include the following:
COVID-19 in children may result in systemic multisystem syndrome with severe outcomes.
Childhood routine vaccination rates drop during pandemic.
COVID-19’s impact in pregnant women unclear, though most cases are asymptomatic.
The COVID-19 pandemic could cause an increase in the prevalence of post-traumatic stress disorder (PTSD).
Complications of opioid addiction will be challenging for the management of disease during the COVID-19 pandemic. Read More

Results and clinical sensitivity and specificity of the ActiveXpress+ COVID-19 Complete Testing Kit based on COVID-19 RT-qPCR result in the UK and Peru.